Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nigella sativa in coronary artery disease
IRCT20190506043494N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2019
- Countries
- 1
01
Overview
Phase 3 trial of nigella sativa in coronary arteriosclerosis, sponsored by Tabriz University of Medical Sciences. Started Nov 2019; status: completed.
02
Drugs
nigella sativa
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20190506043494N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190506043494N1.